The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses.
The FDA has issued warnings about using unapproved versions of semaglutide
Our central scenario reflected our current best-estimate assumptions for these indications, including expectations around future gains in efficacy, reductions in cost, and broader accessibility
LillyDirect has the ability to change the price
Trustpilot: 1.8 (75+ reviews) At a glance: FDA-approved tirzepatide access Brand-name pathway Strong manufacturer credibility Higher pricing than compounded options Poor customer reviews Limited affordability for uninsured patients Verdict What works: Lilly Direct provides one of the lowest-cost FDA-approved tirzepatide currently available
Imaging 2022 , 7456365 (2022)